The release of the new ASCO/CAP guideline recommendations for human epidermal growth factor receptor 2 testing has led to clearer descriptive definitions for immunohistochemistry categories. As soon as we started to use them we realized that an increase in the number of ISH test was occurring. Herein we report our lab data obtained by comparing the semester after the release of the new guidelines with the same semester of the previous year. The impact on routine work practice is highlighted.
Pennacchia, I., Carbone, A., Di Cerbo, A., Vecchio, F. M., Arena, V., 2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice, <<THE BREAST>>, 2015; 24 (3): 285-286. [doi:10.1016/j.breast.2015.01.014] [http://hdl.handle.net/10807/70981]
2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice
Pennacchia, Ilaria;Carbone, Arnaldo;Vecchio, Fabio Maria;Arena, Vincenzo
2015
Abstract
The release of the new ASCO/CAP guideline recommendations for human epidermal growth factor receptor 2 testing has led to clearer descriptive definitions for immunohistochemistry categories. As soon as we started to use them we realized that an increase in the number of ISH test was occurring. Herein we report our lab data obtained by comparing the semester after the release of the new guidelines with the same semester of the previous year. The impact on routine work practice is highlighted.
| File | Dimensione | Formato | |
|---|---|---|---|
|
70981.pdf
non disponibili
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
163.85 kB
Formato
Unknown
|
163.85 kB | Unknown | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
